Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27797987 | 0.73 | — | — | |
| SCHEMBL4809579 | 0.73 | CYP2D6 (0.34) | CYP2D6CYP2C19 | |
| SCHEMBL3509561 | 0.71 | — | — | |
| SCHEMBL3512280 | 0.70 | — | — | |
| SCHEMBL14798711 | 0.70 | — | — | |
| SCHEMBL1495274 | 0.70 | — | — | |
| SCHEMBL12487443 | 0.70 | ACHE (0.35) | CYP2D6 | |
| Hydrochloric Acid SCHEMBL8220484 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL20450562 | 0.69 | — | — | |
| SCHEMBL154678 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011103435-A2 | METHODS FOR FORMING PROTECTED ORGANOBORONIC ACIDS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-08-25 | — | — | WO | claimed |
| CN-114466849-B | N-substituted-3, 4- (fused 5-ring) -5-phenyl-pyrrolidin-2-one compounds as ISOQC and/or inhibitors of QC enzymes | 欣尼克免疫有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20240000947-A1 | POLYPEPTIDE MODIFICATION AND CONJUGATION METHODS | Encodia, Inc. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20230193248-A1 | METHODS FOR PROTEIN IDENTIFICATION BASED ON ENCODING REACTIONS | Encodia, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| CN-114466849-A | N-substituted-3, 4- (fused 5-ring) -5-phenyl-pyrrolidin-2-one compounds as inhibitors of ISOQC and/or QC enzymes | 欣尼克免疫有限公司 | 2022-05-10 | — | — | CN | disclosed |
| EP-2885302-B1 | PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS | GLENMARK PHARMACEUTICALS LTD (IN) | 2018-03-07 | — | — | EP | disclosed |
| US-9908900-B2 | Methods for forming protected organoboronic acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2018-03-06 | — | — | US | disclosed |
| US-9845317-B2 | Slow release of organoboronic acids in cross-coupling reactions | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2017-12-19 | — | — | US | disclosed |
| US-9732102-B2 | System for controlling the reactivity of boronic acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2017-08-15 | — | — | US | disclosed |
| US-9593119-B2 | Process for the preparation of dipeptidylpeptidase inhibitors | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2017-03-14 | — | — | US | disclosed |
| US-8557980-B2 | Methods for forming protected organoboronic acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2013-10-15 | — | — | US | disclosed |
| US-8338601-B2 | Slow release of organoboronic acids in cross-coupling reactions | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-12-25 | — | — | US | disclosed |
| US-8318983-B2 | System for controlling the reactivity of boronic acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-11-27 | — | — | US | disclosed |
| US-20120059184-A1 | System for Controlling the Reactivity of Boronic Acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-03-08 | — | — | US | disclosed |
| US-8013203-B2 | System for controlling the reactivity of boronic acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-09-06 | — | — | US | disclosed |
| WO-2011103435-A2 | METHODS FOR FORMING PROTECTED ORGANOBORONIC ACIDS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-08-25 | — | — | WO | disclosed |
| US-20110201806-A1 | Methods for Forming Protected Organoboronic Acids | NATIONAL SCIENCE FOUNDATION | 2011-08-18 | — | — | US | disclosed |
| US-20100121062-A1 | Slow Release of Organoboronic Acids in Cross-Coupling Reactions | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2010-05-13 | — | — | US | disclosed |
| WO-2010036921-A2 | SLOW RELEASE OF ORGANOBORONIC ACIDS IN CROSS-COUPLING REACTIONS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2010-04-01 | — | — | WO | disclosed |
| US-20090030238-A1 | SYSTEM FOR CONTROLLING THE REACTIVITY OF BORONIC ACIDS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121062-A1 | Slow Release of Organoboronic Acids in Cross-Coupling Reactions | BRS3, CD79B, GRB2 | KMT2A 3510/4885CYP2D6 447/4885CYP2C19 1458/4885 |
| US-20110201806-A1 | Methods for Forming Protected Organoboronic Acids | NISCH, TBCB, DBN1 | KMT2A 3279/4885CYP2D6 312/4885CYP2C19 2136/4885 |
| US-20120059184-A1 | System for Controlling the Reactivity of Boronic Acids | ORC3, BRS3, OSBPL3 | KMT2A 3075/4885CYP2D6 1333/4885CYP2C19 2867/4885 |
| US-20240000947-A1 | POLYPEPTIDE MODIFICATION AND CONJUGATION METHODS | PHAX, PTMS, DNPEP | KMT2A 571/4885CYP2D6 2748/4885CYP2C19 4227/4885 |
| US-20090030238-A1 | SYSTEM FOR CONTROLLING THE REACTIVITY OF BORONIC ACIDS | ORC3, BRS3, OSBPL3 | KMT2A 3075/4885CYP2D6 1333/4885CYP2C19 2867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.